VITALITY 2
Report
- Report Number
- 2124215-2012-13049
- Event Type
- Injury
- Date Received
- October 10, 2012
- Date of Event
- September 13, 2012
- Report Date
- September 13, 2012
- Manufacturer
- GUIDANT CRM CLONMEL IRELAND
- Product Code
- LWS
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT IMPLANTED WITH THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) EXPERIENCED A VENTRICULAR FIBRILLATION (VF) EPISODE THAT RESULTED IN SYNCOPE. THE EPISODE SELF TERMINATED BUT SOME UNDERSENSING WAS NOTED. THE PHYSICIAN DISCUSSED PROGRAMMING THE DEVICE TO BE MORE SENSITIVE. THE PHYSICIAN PLANS TO PERFORM A NON-INVASIVE PROGRAMMED STIMULATION (NIPS) STUDY. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. ADDITIONAL INFORMATION WAS RECEIVED THAT THE PHYSICIAN REPROGRAMMED THE DEVICE TO A MOST SENSITIVE SETTING AND CHANGED THE PATIENT'S MEDICATION. AFTER THESE CHANGES, A DEFIBRILLATION THRESHOLD (DFT) TEST SUCCESSFULLY DETECTED AND CONVERTED THE PATIENT'S VF.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | VITALITY 2 | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | LWS | GUIDANT CRM CLONMEL IRELAND | T175 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 74 YR | Hospitalization| L| R | 1850| T175| 0148 |